PLX
Protalix BioTherapeutics, Inc.
+0.03 (+1.31%)2.72USD73.3K成交股數219M市值11.3本益比(近四季)2.7股價營收比+27.1%營收年增(近四季)2026-11-12下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 19.9M+27% | 33.8M+234% | 9.1M-49% | 17.9M+32% | 15.7M+318% | 10.1M-4% | 18.0M+74% | 13.5M-62% | 3.7M | 10.5M | 10.3M | 35.1M |
| 營業成本 | 7.8M | 4.1M | 4.6M | 8.3M | 5.9M | 8.2M | 8.4M | 9.5M | 2.6M | 8.9M | 4.9M | 6.1M |
| 毛利 | 12.1M+24% | 29.6M+1432% | 4.5M-53% | 9.5M+137% | 9.8M+754% | 1.9M+19% | 9.6M+76% | 4.0M-86% | 1.1M | 1.6M | 5.5M | 28.9M |
| 毛利率 | 61.0% | 87.8% | 49.4% | 53.4% | 62.5% | 19.1% | 53.4% | 29.8% | 30.6% | 15.5% | 52.7% | 82.5% |
| 研發費用 | 4.4M | 5.4M | 5.6M | 4.5M | 6.0M | 3.5M | 3.0M | 3.0M | 2.9M | 3.1M | 3.7M | 4.5M |
| 銷售管理費用 | 3.1M | 3.1M | 3.5M | 2.9M | 2.6M | 2.6M | 2.6M | 3.5M | 3.1M | 4.1M | 3.7M | 4.0M |
| 營業利益 | 4.7M+299% | 21.1M-610% | −4.7M-217% | 2.1M-188% | 1.2M-124% | −4.1M-26% | 4.0M-311% | −2.4M-112% | −4.9M | −5.6M | −1.9M | 20.4M |
| 營業利益率 | 23.5% | 62.7% | -51.1% | 11.9% | 7.5% | -41.0% | 22.2% | -18.0% | -129.6% | -53.5% | -18.2% | 58.2% |
| 稅後淨利 | 3.8M+2203% | 18.3M-606% | −5.5M-270% | 2.4M-207% | 164K-104% | −3.6M-40% | 3.2M-275% | −2.2M-111% | −4.6M | −6.0M | −1.9M | 19.3M |
| 淨利率 | 19.0% | 54.3% | -60.3% | 13.2% | 1.0% | -35.8% | 18.0% | -16.4% | -122.6% | -57.6% | -17.9% | 55.1% |
| 稀釋 EPS | 0.05 | 0.22-540% | -0.06-300% | 0.03-200% | 0.00-100% | -0.05+67% | 0.03-175% | -0.03-114% | -0.06 | -0.03 | -0.04 | 0.21 |
| 稀釋股數 | 82.6M | 83.0M | 78.5M | 80.8M | 81.3M | 76.6M | 81.2M | 73.3M | 73.0M | 82.4M | 83.8M | 83.2M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 27.4M | 41.0M | 14.7M | 13.6M | 17.9M | 19.5M | 27.4M | 23.4M | 27.2M | 23.6M | 20.4M | 48.2M |
| 應收帳款 | 16.5M | 2.9M | 8.8M | 14.4M | 9.4M | 4.7M | 2.2M | 10.1M | 3.8M | 5.3M | 8.9M | 4.0M |
| 存貨 | 32.3M | 30.5M | 25.7M | 21.3M | 21.1M | 19.5M | 17.2M | 20.7M | 22.3M | 19.0M | 21.6M | 19.6M |
| 總資產 | 110M | 102M | 82.3M | 82.3M | 78.5M | 73.9M | 61.6M | 91.5M | 89.8M | 84.4M | 87.6M | 88.4M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 38.9M | 35.1M | 34.1M | 29.4M | 28.6M | 28.7M | 29.1M | 63.0M | 60.0M | 50.9M | 49.3M | 49.4M |
| 股東權益 | 71.4M | 67.2M | 48.2M | 52.9M | 49.9M | 45.2M | 32.4M | 28.6M | 29.8M | 33.6M | 38.2M | 39.0M |
| 負債比 | 35.3% | 34.3% | 41.4% | 35.7% | 36.4% | 38.8% | 47.3% | 68.8% | 66.8% | 60.2% | 56.3% | 55.9% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | 22.0M-535% | – | – | – | −5.1M | – | – | 4.2M | – | – | – |
| 資本支出 | – | 761K | – | – | – | 306K | – | – | 598K | – | – | – |
| 自由現金流 | – | 21.3M-496% | – | – | – | −5.4M | – | – | 3.6M | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | 63.0% | – | – | – | -53.0% | – | – | 95.8% | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 52.7M
| Single Operating | 52.7M | 100.0% | -1.2% |
|---|
產品／服務2025 年度 · 52.7M
| 產品 | 51.8M | 98.2% | -2.2% |
|---|---|---|---|
| License And Service | 942K | 1.8% | +125.4% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 52.7M | -1.2% | −6.6M | -12.5% | -0.08 | −13.6M |
| FY2024 | 53.4M | -18.5% | 2.9M | 5.5% | 0.04 | 7.4M |
| FY2023 | 65.5M | +37.5% | 8.3M | 12.7% | 0.09 | −2.5M |
| FY2022 | 47.6M | +24.2% | −14.9M | -31.3% | -0.31 | −25.6M |
| FY2021 | 38.4M | -39.0% | −27.6M | -71.9% | -0.62 | −11.7M |
| FY2020 | 62.9M | +15.0% | −6.5M | -10.4% | -0.22 | −26.8M |
| FY2019 | 54.7M | +59.7% | −18.3M | -33.4% | -1.23 | −20.0M |
| FY2018 | 34.2M | – | −26.5M | -77.3% | -1.80 | −8.4M |